FibroGen Ownership | Who Owns FibroGen?
FibroGen Ownership Summary
FibroGen is owned by 26.23% institutional investors, 1.58% insiders, and 72.19% retail investors. Blackrock is the largest institutional shareholder, holding 2.43% of FGEN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.89% of its assets in FibroGen shares.
FGEN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | FibroGen | 26.23% | 1.58% | 72.19% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 2.41M | 2.43% | $2.15M |
| Jacobs levy equity management | 2.10M | 2.13% | $1.88M |
| Aqr capital management | 1.32M | 1.33% | $1.18M |
| Millennium management | 830.61K | 0.83% | $439.81K |
| Fmr | 414.58K | 0.41% | $219.52K |
| Connective capital management | 15.00K | 0.37% | $79.50K |
| Cubist systematic strategies | 287.33K | 0.29% | $256.39K |
| Morgan stanley | 236.48K | 0.24% | $211.01K |
| Bank of america corp /de/ | 160.88K | 0.16% | $143.51K |
| Nomura | 139.60K | 0.14% | $124.56K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Connective capital management | 15.00K | 0.07% | $79.50K |
| Jacobs levy equity management | 2.10M | 0.01% | $1.88M |
| Aqr capital management | 1.32M | 0.00% | $1.18M |
| Cubist systematic strategies | 287.33K | 0.00% | $256.39K |
| Nomura | 139.60K | 0.00% | $124.56K |
| Millennium management | 830.61K | 0.00% | $439.81K |
| Public employees retirement system of ohio | 21.03K | 0.00% | $18.76K |
| Proshare advisors | - | - | - |
| Voya investment management | - | - | - |
| Price t rowe associates inc /md/ | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Aqr capital management | 1.32M | 0.00% | 769.59K |
| Cubist systematic strategies | 287.33K | 0.00% | 280.16K |
| Nomura | 139.60K | 0.00% | 139.60K |
| Susquehanna group, llp | 134.21K | - | 78.85K |
| Fmr | 414.58K | - | 31.32K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -8.50M |
| Vanguard group | - | - | -5.86M |
| Blackrock | 2.41M | - | -4.56M |
| Acadian asset management | - | - | -3.91M |
| Primecap management co/ca/ | - | - | -3.74M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Nomura | 139.60K | 0.00% | 139.60K | $124.56K |
| Connective capital management | 15.00K | 0.07% | 15.00K | $79.50K |
| Parallax volatility advisers | 10.00K | - | 10.00K | $8.92K |
| Macquarie group | 4.65K | - | 4.65K | $4.15K |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -1.00 |
| Point72 (difc) | -13.00 |
| Us bancorp \de\ | -29.00 |
| Nelson, van denburg & campbell wealth management group | -35.00 |
| Southstate | -105.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 30 | -46.43% | 1,060,110 | -96.79% | 26 | 2.46% | 5 | -76.19% | 24 | 60.00% |
| Mar 31, 2025 | 56 | -20.00% | 32,974,661 | -9.03% | 32 | 2.51% | 21 | -16.00% | 15 | -37.50% |
| Dec 31, 2024 | 70 | -4.11% | 36,247,264 | -21.09% | 36 | 1.73% | 25 | 25.00% | 24 | -20.00% |
| Sep 30, 2024 | 73 | -33.64% | 45,933,468 | -18.80% | 45 | 1.40% | 22 | -59.26% | 29 | -21.62% |
| Jun 30, 2024 | 110 | -5.98% | 56,568,035 | -7.77% | 57 | 1.44% | 54 | 1.89% | 37 | -13.95% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 2.92M | 2.89% | -1.00 |
| Vanguard Total Stock Mkt Idx Inv | 114.18K | 2.82% | -2.50K |
| PRIMECAP Odyssey Aggressive Growth | 2.64M | 2.63% | -1.27M |
| Vanguard Capital Opportunity Inv | 67.98K | 1.68% | -56.34K |
| PRIMECAP Odyssey Growth | 1.57M | 1.56% | -826.01K |
| Vanguard Institutional Extnd Mkt Idx Tr | 37.95K | 0.94% | -17.29K |
| Vanguard Strategic Small-Cap Equity Inv | 898.60K | 0.89% | - |
| Fidelity Extended Market Index | 22.23K | 0.55% | -59.00 |
| Fidelity Enhanced Small Cap ETF | 361.69K | 0.36% | 527.00 |
| NT R2000 Value Index Fund - NL | 308.69K | 0.31% | 34.29K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 30, 2025 | Schoeneck James A | - | Buy | $119.48K |
| Mar 24, 2025 | Wettig Thane | CEO | Buy | $50.66K |
| Mar 20, 2025 | Schoeneck James A | - | Buy | $88.00K |
| Mar 21, 2025 | Schoeneck James A | - | Buy | $17.04K |
| Jun 12, 2024 | Adib Deyaa | Chief Medical Officer | Buy | $25.88K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 1 | - |
| 2025 Q1 | 3 | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | 1 | - |
FGEN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools